Cargando…

Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study

OBJECTIVES: To examine adherence to serum creatinine and potassium monitoring and discontinuation guidelines following initiation of treatment with ACE inhibitors (ACEI) or angiotensin receptor blockers (ARBs); and whether high-risk patients are monitored. DESIGN: A general practice-based cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Morten, Mansfield, Kathryn E, Bhaskaran, Krishnan, Nitsch, Dorothea, Sørensen, Henrik Toft, Smeeth, Liam, Tomlinson, Laurie A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223644/ https://www.ncbi.nlm.nih.gov/pubmed/28069618 http://dx.doi.org/10.1136/bmjopen-2016-012818

Ejemplares similares

Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study
por: Schmidt, Morten, et al.
Publicado: (2017)

Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study
por: Mansfield, Kathryn E, et al.
Publicado: (2016)

Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin–angiotensin system blockers: a UK primary care cohort study
por: Sinnott, Sarah-Jo, et al.
Publicado: (2017)

Correction: Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study
Publicado: (2017)

Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care
por: Bidulka, Patrick, et al.
Publicado: (2020)

Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
por: Bandak, Ghassan, et al.
Publicado: (2017)

Prevalence, incidence, indication, and choice of antidepressants in patients with and without chronic kidney disease: a matched cohort study in UK Clinical Practice Research Datalink
por: Iwagami, Masao, et al.
Publicado: (2017)

Acute Pericarditis and Cancer Risk: A Matched Cohort Study Using Linked UK Primary and Secondary Care Data
por: Søgaard, Kirstine Kobberøe, et al.
Publicado: (2018)

Long-term effects of bariatric surgery on acute kidney injury: a propensity-matched cohort in the UK Clinical Practice Research Datalink
por: Koppe, Uwe, et al.
Publicado: (2018)

Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population‐based cohort study
por: Iwagami, Masao, et al.
Publicado: (2018)

Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis
por: Mansfield, Kathryn E, et al.
Publicado: (2018)

Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data
por: Iwagami, Masao, et al.
Publicado: (2018)

Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database
por: Bhaskaran, Krishnan, et al.
Publicado: (2012)

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
por: Ravid, Mordchai
Publicado: (2009)

Renin–angiotensin system blockade for the risk of cancer and death
por: Shen, Jian, et al.
Publicado: (2016)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Left ventricular hypertrophy and renin-angiotensin system blockade
por: Cowan, Brett R., et al.
Publicado: (2009)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

Diagnosis of acute kidney injury and its association with in-hospital mortality in patients with infective exacerbations of bronchiectasis: cohort study from a UK nationwide database
por: Iwagami, Masao, et al.
Publicado: (2016)

Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom
por: Iwagami, Masao, et al.
Publicado: (2018)

Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink
por: Goh, Kah L, et al.
Publicado: (2015)

Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study
por: Crellin, Elizabeth, et al.
Publicado: (2018)

Ethnic differences in hypertension management, medication use and blood pressure control in UK primary care, 2006–2019: a retrospective cohort study
por: Eastwood, Sophie V., et al.
Publicado: (2022)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary care
por: Herrett, Emily, et al.
Publicado: (2022)

Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
por: Bobkova, Irina, et al.
Publicado: (2020)

Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
por: Laverman, Gozewijn D., et al.
Publicado: (2011)

Retarding the progression of chronic kidney disease with renin angiotensin system blockade
por: Limesh, M., et al.
Publicado: (2012)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
por: Bloch, Michael J.
Publicado: (2020)

Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?
por: Lee, Hak Seung, et al.
Publicado: (2020)

Risk of lung cancer and renin–angiotensin blockade: a concise review
por: Rachow, Tobias, et al.
Publicado: (2020)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
por: South, Andrew M., et al.
Publicado: (2020)

The risk of acute kidney injury in colorectal cancer survivors: an english population-based matched cohort study
por: Andresen, Kirsty, et al.
Publicado: (2023)

Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study
por: Bidulka, Patrick, et al.
Publicado: (2020)

The comparative effectiveness of fourth‐line drugs in resistant hypertension: An application in electronic health record data
por: Sinnott, Sarah‐Jo, et al.
Publicado: (2019)

Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease
por: Garlo, Katherine G., et al.
Publicado: (2018)

Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System
por: Tanios, Bassem Y., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_09s895fq6np3bjkjfcmrraqk6r